What to Expect at Europe’s Leading Biomarker & Drug-Diagnostic Co-Development Forum
Europe accelerates its precision medicine ecosystem propelled by IVDR implementation, expanding molecular testing capacity, and coordinated early detection initiatives, the 16th World Clinical Biomarkers & Companion Diagnostics showcases the region’s latest advances in biomarker-guided trials, CDx regulation, and cross-border drug-diagnostic co-development to accelerate access to targeted therapies across oncology and beyond. Uniting leading decision makers from biopharma, diagnostic developers, regulatory bodies, healthcare institutions, and testing laboratories, this summit empowers scalable, timely, and equitable diagnostic adoption for diverse patient populations across Europe.
Unmissable Event Highlights
Advancing the Hottest Biomarkers & IVD Platforms
Tap into the latest novel endpoint data spanning MRD, ctDNA and digital pathology and observe how global precision medicine partnerships are fuelling access to earlier detection, improved selection and monitoring impact with BIVDA, The Newcastle upon Tyne Hospitals NHS Foundation Trust and Johnson & Johnson
Optimizing Biomarker Operation & Translational Studies
Explore dynamic tumour profiling, gene signatures, functional, ligand binding and genomic assays, alongside the critical biomarker operations and pre-analytics workflows needed to fuel biomarker strategies with GSK, Moderna, Corbus Pharmaceuticals and Step Pharma
Fuelling Precision Medicine Beyond Oncology
Uncover precision medicine applications in neurologic, chronic and rare diseases with gene panels, digital and multiplex biomarkers for earlier detection, improved stratification, and enhanced patient access to targeted therapies with Moderna and Avacta Therapeutics
Navigating IVDR Compliance For Streamlined Rx-Dx Approvals
Plan for early IVDR compliance and correct regulatory filing with insights from regional competent and notified bodies to unlock timely and equitable access, not least in the wake of the COMBINE Pilot with Paul-Ehrlich-Institut, Bayer, Sanofi and TÜV Rheinland
Strengthening the Roadmap from Brench-to-Bedside
Ensure day-one readiness with improved knowledge of knowledge of HTAs, pricing, the use of real-world data and HCP adoption to overcome barriers in precision medicine access with AbbVie, UCB and the University of Glasgow
Divide & Conquer
With ever-growing Rx-Dx partnerships, policy evolution and precision medicine access initiatives we have meticulously researched with subject matter experts to identify the key challenges facing the community across indications, biomarkers, biopsy types, testing technologies and drug modalities.
By splitting into 3 end-to-end tracks (Biomarker Discovery & Translation, Clinical & CDx Development & Rx-Dx Commercialisation & Adoption), our speakers have tailored their presentations to dive into specific challenges for those stages of development.
By sending different members of the team across the drug pipeline, you can be sure you’ve left no stone unturned and have a team inspired with actionable takeaways to apply to their work.
A snapshot of key sessions featured in each track across the 2026 program:
Download Full Event Guide
- Free* to Attend for Biopharma & Academia
- Europe’s Leading Biomarker & Companion Diagnostic Forum
- Solid Tumour & Liquid Biopsy Biomarker Strategies
- Oncology, Neurological & Infectious Disease Case Studies
Attending Companies Include
Providing the ultimate global forum to showcase new and emerging precision medicine strategies, 2026 brings you an all-star line up of X+ new biotech entrants from pioneering targeted small molecule, ADCs, novel conjugate, cell and gene therapy precision medicines.
Explore the Agenda
Gain first-hand insights into the latest translational, clinical and commercial strides shaping biomarker-led trials and CDx approvals. From IVDR, to the COMBINE pilot, explore Europe’s most innovative precision medicine advances through a packed agenda of expert-led sessions and exclusive Rx-Dx partnership discussions
Partner With Us
Position your brand alongside leading global and European-local IVD innovators, clinical and biosample management leaders and laboratory service to stay of the pinnacle of bringing precision therapeutics from bench-to-bedside
Join Biopharma Experts
Join Europe’s most comprehensive and trusted senior precision medicine community for dynamic and high-impact conversations across diverse precision medicine therapy areas, modalities, biosample types and testing platforms